Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

December 23, 2024

🎆 2024: a year of stories that made us smile, think and grow

Take a heartwarming walk down the 2024 memory lane. Relive highlights from breakthrough discoveries to patient journeys — and one long flight path.
Carla Strom, MLA
December 12, 2024

Carla Strom named Vanderbilt-Ingram Community Outreach and Engagement director 

She is responsible for working with colleagues to develop initiatives for supporting community engagement and addressing health care disparities.

By Tom Wilemon
December 10, 2024

Study identifies that higher West African ancestry may contribute to worse breast cancer outcomes 

The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.

By Tom Wilemon
Heather Jackson, PhD, APRN, FNP-BC. (photo by Donn Jones)
November 22, 2024

Heather Jackson named America’s top NP for pain management 

Jackson treats patients at the supportive and palliative oncology clinic at Vanderbilt-Ingram Cancer Center and is an associate professor in Clinical Nursing at Vanderbilt University.

By Tom Wilemon
November 13, 2024

New Video: Only half of young cancer patients report discussing fertility preservation

Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of a fertility preservation discussion.

By Tom Wilemon
November 11, 2024

Southern Environmental Health Study recruiting participants 

People who sign up can help researchers assess whether environmental factors may be the culprits behind the region’s higher cancer burden.

By Tom Wilemon
November 4, 2024

Tae Kon Kim receives V Foundation grant for MDS drug research 

Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS.
By Tom Wilemon
October 31, 2024

Chic Awearness surpasses $1 million for ovarian cancer research and patient support 

Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives.
By Tom Wilemon and Erin O. Smith
October 30, 2024

Michael Gibson votes with FDA panel to limit immunotherapy indication 

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. 
By Tom Wilemon
October 15, 2024

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.
By Tom Wilemon
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.
By Tom Wilemon
October 7, 2024

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.
By Tom Wilemon
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.
By Tom Wilemon
1 2 3 … 26